ArticleJournal of experimental & clinical cancer research : CR2025

Hypoxia-inducible APCDD1L-AS1 promotes osimertinib resistance by stabilising DLST to drive tricarboxylic acid cycle in lung adenocarcinoma.

Quanli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.